Koers Aradigm Corporation OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
Omzet 2016 | 195K 180K | Omzet 2017 | 14,46 mln. 13,33 mln. | Marktkapitalisatie | 97,3 mln. 89,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | -32 mln. -29,49 mln. | Nettowinst (verlies) 2017 | -10 mln. -9,22 mln. | EV/omzet 2016 | 73,3 x |
Nettoliquiditeiten 2016 | 9,37 mln. 8,64 mln. | Nettoschuld 2017 | 7,91 mln. 7,29 mln. | EV/omzet 2017 | 7,27 x |
K/w-verhouding 2016 |
-0,72
x | K/w-verhouding 2017 |
-9,3
x | Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 |
-
| Vrij verhandelbaar | 60,28% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,05% | 63,85 mld. | |
-2,02% | 41,83 mld. | |
+40,01% | 40,47 mld. | |
-10,22% | 27,17 mld. | |
+13,42% | 26,52 mld. | |
-21,60% | 18,69 mld. | |
+2,89% | 12,73 mld. | |
+22,40% | 12,11 mld. | |
+27,49% | 12,07 mld. |